Search Results 211-220 of 2951 for ✍원벳원 [원탑보증.com/가입코드 111] 올인구조대 ✍

  1. Ph 1b Study to Evaluate GSK2110183 in Combination with Bortezomib and Dexamethasone in Subjects with Multiple Myeloma - Mayo Clinic

    Phase Ib, open-label study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and clinical activity of GSK2110183 dosed in ...

  2. A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors - Mayo Clinic

    Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...

  3. Safe Clinics - Mayo Clinic

    About this study. The purpose of this study is to assist child health providers to better understand and support pediatric patient clinical care needs ...

  4. Mayo Clinic

    ... . VID-20115872. Home; Brightcove-Brain Tumor Patient Story-Kims Story. Double your impact on cancer! Give Now. Make a gift before July 31 and it can be ...

  5. Study of Oral LOXO-338 in Patients With Advanced Blood Cancers - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. A Registry to Collect Human Bio-Specimens from Healthy Volunteers to Support Clinical Protocol Development

    The purpose of this registry is to collect human biospecimens for the support of new clinical protocol development and produce clinical grade cells and tissue ...

  7. Validation of Uroflow Trace (R) Mobile Application - Mayo Clinic

    The purpose of this study is to see if the Uroflow Trace (r) mobile application provides an accurate representation of urinary flow tracing by comparing it to a ...

  8. Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) - Mayo Clinic

    The purpose of this study is to determine how well SNS01-T is tolerated by relapsed or refractory multiple myeloma, B cell lymphoma or plasma cell leukemia ...

  9. A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression - Mayo Clinic

    The purpose of this study is to obtain an estimate of the biochemical response rate as determined by CA125 response using the Gynecologic Cancer Intergroup ( ...

  10. A Study Evaluating ABT-199 in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy - Mayo Clinic

    About this study. The primary objectives of this study are to assess the safety profile, characterize pharmacokinetics (PK) and determine the dosing ...